Search Results
Found 70 results for "VIG" across articles, medicines, trials, companies and the glossary
MedicinesAll 18 →
Aimovig 140 mg Solution for injectionERENUMAB · Novartis Pharma GmbH
Aimovig 70 mg Solution for injectionERENUMAB · Novartis Europharm Limited
Deqsiga 100 mg/mL solution for infusion/human normal immunoglobulin (IVIg)Human Normal Immunoglobulin (IV) · Takeda Manufacturing Austria AG
Divigel 0.1% w/w Gel, 1 mg/doseEstradiol · Orion Corporation
Divigel 0.1% w/w Gel, 1 mg/doseEstradiol · Merit Pharmaceuticals Limited
KAVIGALE 300 mg solution for injection/infusionSipavibart · AstraZeneca AB
Industry
The €8.5 Billion Defense: Dutch Innovative Pharma Fights Back Against Cost-Control Policies
The Dutch Association for Innovative Medicines (VIG) releases a detailed report highlighting the sector\'s €8.5 billion gross added value, warning that cost-containment measures threaten patient access, clinical trials, and Europe\'s biopharma sovereignty.
Regulatory Affairs
After the Mother of All Deals: A Blueprint for the Ireland-India Pharmaceutical Corridor Under the EU-India FTA
A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.
Industry
Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare
Intel has announced a massive €5 billion ($5.7 billion) capital investment at its Leixlip campus in Ireland to expand semiconductor manufacturing capacity, driven by global demand for AI and high-performance computing.
Regulatory Affairs
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Irish Health Minister Jennifer Carroll MacNeill positions the €10 billion EU Biotech Act as a key priority for Ireland's Council Presidency, aiming to reverse the decline in clinical trials while balancing pharmaceutical incentives against patient access to affordable therapies.
Industry
Tapestry VC Closes $80M Fund III Backed by British Business Bank to Target Repeat Founders
Co-founded by Patrick Murphy and David Kelly, Tapestry VC has announced the closing of its $80 million Fund III, tripling its capital base with support from OpenAI CFO Sarah Friar and the British Business Bank.
Regulatory Affairs
A Global Milestone for Wellness: Chanelle McCoy Health Secures Historic Dual SFDA and European Novel Food Regulatory Approvals
In a landmark world-first, Irish-founded Chanelle McCoy Health has received official regulatory approvals from the Saudi Food and Drug Authority and confirmation of safety under EU Novel Food guidelines for its Pureis® Ultra Pure CBD range.
Regulatory Affairs
The Digital and Regulatory Frontier: Top 10 Technical and GMP Trends Shaping Pharma in 2026
A comprehensive technical report detailing the top 10 trends in Good Manufacturing Practice (GMP), sterile manufacturing, GAMP 5, Quality 4.0, and continuous manufacturing currently reshaping the global pharmaceutical landscape.
Industry
Funding the Future: Inside the €75k Women TechEU and £10M Createch Grants for Startups and SMEs
An in-depth analysis of two newly opened funding opportunities—Women TechEU and Innovate UK's Next Wave Createch—designed to support early-stage deep tech and creative technology innovators across Europe and the UK.
Regulatory Affairs
Understanding the Common Technical Document (CTD) Structure for Global Regulatory Submissions
An explanation of the 5 modules of the ICH Common Technical Document (CTD) format required for global drug marketing authorization applications.
Regulatory Affairs
Navigating Global Price Controls: How the US Inflation Reduction Act and Evolving EU Policies Shape R&D in 2026
As global health systems enforce tighter pricing controls under the US IRA and EU health technology updates, biopharma majors are restructuring their R&D portfolios to manage clinical risks.
Regulatory Affairs
B2B Scaling Roundtable: Fieldfisher to Host Dublin Tech Founders on July 1st
Legal firm Fieldfisher will host a scaling roundtable for B2B founders and sales leaders in Dublin on July 1st, featuring legal guidance from Jamie Woodcock and leadership coaching from Fergus McFadden.
Industry
The Irish Startup Ecosystem: A Comprehensive Funding and Development Guide for Entrepreneurs
From Enterprise Ireland feasibility grants and Local Enterprise Office funding to seed venture capital and angel networks, this is the ultimate blueprint for starting and scaling a business in Ireland.
Regulatory Affairs
Addiction Counsellors of Ireland Launch Strategic Plan 2026–2029 to Prepare for CORU Regulation
Presented at the ACI’s Annual General Meeting in Carlow by Minister Jennifer Murnane O’Connor and ACI Board member John Devlin, the new three-year strategy focuses on workforce recognition, professional development, and regulatory transitions.
Biotechnology
Life Science PR in 2026: The Complete Guide to Building Authority, Winning Media Coverage, and Controlling Your Narrative
A definitive 5,000-word guide to public relations for pharmaceutical, biotech, and MedTech professionals. Learn how to build a PR strategy from scratch, which tools to use, how to write for journalists and LinkedIn, and the exact frameworks used by the world's leading life science communications teams.
LinkedIn
LinkedIn PR for Life Science & Pharma: The Definitive Guide to Building Credibility, Authority, and Visibility in 2026
A practitioner-level guide to building genuine professional authority on LinkedIn as a pharmaceutical, biotech, or MedTech professional. Covers profile architecture, content strategy, engagement tactics, thought leadership frameworks, and the exact playbooks used by the most followed life science voices on the platform.
Regulatory Affairs
Pharmaceutical Regulatory Update 2026: EU, UK, FDA & Global Changes Explained
A massive wave of regulatory reform is sweeping the global pharma industry in 2026. From the EU's most significant legislative overhaul in decades to the FDA's sweeping Operation TrialBlazer, we break down what quality, manufacturing, and regulatory teams need to know to stay compliant.
Regulatory Affairs
Eli Lilly Adapts Direct-to-Patient Model for UK Market with LillyDirect Launch
Eli Lilly has successfully brought its LillyDirect service to the UK. Adapted to comply with strict local regulations, the service partners with regulated healthcare organizations to offer secure, anti-counterfeit delivery of high-demand therapies like Mounjaro directly to patients' doors.
Industry
Navigating Ireland’s Pharma Dependency: Strategies for Policy and Talent in an Uncertain Era
With pharmaceuticals making up 20% of Ireland’s GDP, the nation’s reliance on the industry brings immense economic benefit but notable risks. We explore how Ireland must adapt its policy, manage geopolitical headwinds, and aggressively attract skilled labour to secure its future.
Regulatory Affairs
Beyond the Headline: Are Irish Pharma Workers Truly the Highest Paid in Europe?
Recent reports suggest Irish pharma workers are the highest paid in Europe, but a deeper dive reveals a more complex reality. We analyze compensation packages, tax regimes, and cost of living across Europe’s top pharmaceutical hubs.
Industry
Irish Universities Association Launches Strategy 2026-2030 to Navigate Technological and Global Shifts
The IUA has unveiled its ambitious five-year strategy, built around five core priorities: Advocacy, Alignment, Agility, Access, and Accountability, aimed at securing the future of Ireland's higher education sector.
MedTech
How to Overcome Middle Management Resistance to AI in Ireland’s Pharma Sector: 5 Root Causes and Targeted Interventions
Middle managers stall more AI rollouts than bad technology does. Here are the 5 root causes of that resistance and the interventions that convert it to active advocacy within 90 days-specifically tailored for Ireland’s thriving Pharmaceutical and MedTech sectors.
Pharmaceutical
Status Yellow High Temperature Warning Issued for Ireland — Your Complete Health & Safety Guide
Met Éireann has issued a Status Yellow High Temperature Warning for Ireland. Here is everything you need to know: how to protect yourself and your family, what to eat and drink, what to keep at home, and the key precautions recommended by HSE and public health experts.
LinkedIn
LinkedIn for Medical Science Liaisons (MSLs): The Complete Guide to Showcasing Scientific Expertise Without Violating Compliance
A step-by-step compliance-safe LinkedIn guide exclusively for Medical Science Liaisons. Covers profile optimisation, what to post, what never to post, KOL engagement, off-label rules, digital medical affairs strategy, and how to build scientific credibility on LinkedIn without breaching pharmaceutical regulatory guidelines.
Regulatory Affairs
How to Build a Powerful Personal Brand in Pharma Without Sharing Proprietary Data
A complete step-by-step guide for pharmaceutical, biotech and life science professionals on building a credible, visible personal brand on LinkedIn - without ever crossing compliance lines or risking proprietary data exposure. Covers brand strategy, content pillars, storytelling frameworks, and the exact boundaries every pharma professional must respect.
LinkedIn
How to Highlight Regulatory Affairs and Compliance Expertise on Your LinkedIn Profile
A detailed step-by-step LinkedIn guide for Regulatory Affairs Specialists, Quality Assurance professionals, Pharmacovigilance Officers, CMC Scientists, and all pharmaceutical compliance professionals. Learn exactly how to frame your regulatory expertise on LinkedIn to attract the right roles, visibility, and recognition - without exposing proprietary submissions or confidential regulatory strategy.
Pharmaceutical
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Ireland’s Life Sciences Sector
An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.
Regulatory Affairs
How Most Favored Nation (MFN) Pricing Impacts Drug Development & Launch Planning
An expert analysis of the strategic shifts required in global drug development, indication sequencing, and launch timelines in response to proposed Most Favored Nation pricing and the Inflation Reduction Act.
Industry
AbbVie Nears $11 Billion Acquisition of Apogee Therapeutics to Bolster Immunology Pipeline
AbbVie is reportedly in advanced negotiations to acquire clinical-stage biotech Apogee Therapeutics for approximately $10.9 billion in cash, aiming to secure the promising long-acting eczema therapy zumilokibart.
Clinical Trials
J-Pharma and Uniphar Advance Nanvuranlat into Global Phase III Trial for Biliary Tract Cancer
Japanese biotech J-Pharma and Ireland-based Uniphar have received FDA alignment to bypass Phase II and advance nanvuranlat (JPH203) directly into a pivotal global Phase III study for second-line biliary tract cancer.
Industry
The 47% Problem: Is the Irish Graduate Job Market Broken?
A staggering 47% of Irish employers have slashed entry-level and graduate roles in 2026. What does this massive structural shift mean for the Class of 2025 and 2026, and how can graduates pivot to survive the "entry-level paradox"?
Regulatory Affairs
Breckenridge Pharmaceutical Issues Major Recall for Duloxetine Capsules
Breckenridge Pharmaceutical has initiated a voluntary recall of hundreds of thousands of bottles of Duloxetine Delayed-Release Capsules due to the presence of nitrosamine impurities exceeding FDA limits.
Pharmaceutical
Enterprise Ireland Reports Record €38.86bn in Exports: What It Means for Indigenous Life Sciences
Enterprise Ireland has announced record total exports of €38.86 billion. With the Advanced Manufacturing and Life Sciences sector surging by 14% to €13.16 billion, we analyse what this means for Ireland's homegrown pharma ecosystem.
Regulatory Affairs
Consumer Watchdog Launches Major Probe into Retail Pharmacy Sector Pricing
The Competition and Consumer Protection Commission (CCPC) has launched a comprehensive market study into Ireland's retail pharmacy sector, targeting opaque pricing practices and a lack of competition.
Pharmaceutical
Ireland in the Crosshairs: How New U.S. Tax Rules and Trade Policies Threaten the Irish Pharma Boom
New U.S. disclosure regulations and aggressive "America First" trade policies from the Trump administration have exposed the massive tax payments of U.S. pharmaceutical giants in Ireland, placing the country's fiscal stability under intense scrutiny.
Biotechnology
The European Biotech Act 2026: A Catalyst for Competitiveness and Innovation in Health Biotechnology
The European Commission has proposed the European Biotech Act to turbocharge the EU's health biotechnology sector, streamline regulations, and regain global competitiveness against the US and China.
Clinical Trials
Navigating Challenges in Oncology: Jazz Pharmaceuticals and PharmaMar Stay Committed Despite Phase 3 Setback
In the rigorous and highly demanding landscape of oncology research, scientific progress is often non-linear. Recently, Jazz Pharmaceuticals and its partner PharmaMar announced that their Phase 3 trial evaluating Zepzelca did not meet its primary endpoint.
LinkedIn
How to Create a LinkedIn Profile Using AI: The 2026 Guide for Life Science Professionals
Step-by-step guide to building a standout LinkedIn profile using ChatGPT and AI tools - written for pharma, biotech, and MedTech professionals in Ireland. Includes copy-paste AI prompts for every section.
MedTech
Medtronic Completes $550M Acquisition of Scientia Vascular to Advance Neurovascular Care
Galway-headquartered Medtronic has completed its $550 million acquisition of Scientia Vascular, integrating best-in-class guidewires and catheters into its neurovascular portfolio to transform stroke treatment globally.
Industry
Europe's United Front: How the Beneluxa Initiative is Defending the Pharma Framework Against US Pricing Pressure
With the US pushing for individual drug pricing deals and Germany slashing healthcare spending, the Beneluxa Initiative represents five European nations calling for a unified, coordinated approach to protect Europe's pharmaceutical innovation and access to medicines in 2026.
Industry
The Ultimate Guide to Startup Funding in Ireland (2026)
Navigating the Irish startup ecosystem? Discover our comprehensive, step-by-step breakdown of seed funding, accelerator programs, and grants available from Enterprise Ireland, LEO, NDRC, and more in 2026.
Regulatory Affairs
FDA 21 CFR Part 211 vs. EU GMP Annex 1: Key Differences
A comprehensive breakdown of the core differences between US FDA 21 CFR Part 211 and EU GMP Annex 1 for sterile and non-sterile pharmaceutical manufacturing.
Biotechnology
Life Science PR: Why Public Relations and Social Media Management is Critical for Pharma
A comprehensive guide on why Life Science PR is essential for pharmaceutical and biotech firms, how to manage corporate reputation, and critical social media guidelines employees must follow before publishing on LinkedIn.
LinkedIn
The Ultimate Guide to LinkedIn's SSI Score for Pharma and HR Professionals
Discover what the LinkedIn Social Selling Index (SSI) is, how to find your score, and proven strategies to improve your 4 pillars. A complete guide tailored for pharmaceutical sales reps, recruiters, and life science professionals.
MedTech
From Generative to Agentic: How Multi-Agent AI Workflows Are Automating Clinical Trials in Ireland
An in-depth analysis of the shift from passive generative AI to active agentic AI in clinical research. We explore how Irish clinical trial teams use multi-agent workflows to automate administrative burdens, GxP validation via local frameworks like Ollama, and how Priya LifePDF ensures document privacy.
MedTech
The Digital-First Regulatory Landscape: How Ireland's Life Science Sector Is Adapting to the EU AI Act, EHDS, and Governance by Design
A comprehensive guide for Irish pharmaceutical, MedTech, and life science professionals on the EU AI Act implementation, the European Health Data Space, cGMP compliance in an AI-driven environment, ALCOA+ in digital systems, and the practical steps organisations must take to achieve governance by design in 2026.
MedTech
AI Tools for Life Science and Pharma 2026: ChatGPT vs Claude vs Gemini vs Perplexity, Complete Pricing Guide and Decision Framework
A complete 2026 guide for pharmaceutical and life science professionals on choosing the right AI tool. Detailed pricing breakdown, comparison tables, regulatory guidance (FDA, EU GMP, ICH Q10, HPRA), and a step-by-step decision framework for QA/QC, regulatory affairs, and R&D teams.
Industry
The Biology and Conservation of River Turtles: Sentinel Species of Freshwater Ecosystems
River turtles are more than prehistoric survivors; they are critical indicators of freshwater health. Discover the biology, ecological roles, and cutting-edge conservation technologies being used to save these sentinel species from extinction.
Regulatory Affairs
Free GMP Document Stamp Tool for Irish Pharma: Apply APPROVED, DRAFT and CONTROLLED COPY to PDFs Without Cloud Upload
Irish pharma, MedTech and life science teams can now apply GMP-standard status stamps to pharmaceutical PDFs entirely in their browser - with zero file upload, zero server, and full compliance with GDPR Article 25, EU GMP Annex 1, FDA 21 CFR Part 11, and HPRA requirements.
Pharmaceutical
How the Iran Conflict Is Disrupting Ireland’s Pharmaceutical Industry and Why It Matters Globally.
Middle East air route disruptions are raising costs and delaying Ireland’s pharma exports, impacting global medicine supply chains.
Regulatory Affairs
The New Frontier in Pharma: Plant-Derived Cannabinoid APIs
Cannabinoid APIs are transforming pharma with precise, plant-derived medicines, balancing sustainability, regulation, and innovation.